ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Invesco S&P SmallCap Health Care ETF
53.33
+0.3776
0.71%
盤後:
53.34
0.0108
+0.02%
19:30 EDT
成交量:
1.03萬
成交額:
55.10萬
市值:
1.80億
市盈率:
- -
高:
53.38
開:
52.99
低:
52.99
收:
52.95
52周最高:
56.45
52周最低:
39.08
股本:
337.00萬
流通股本:
337.00萬
量比:
0.93
換手率:
0.31%
股息:
0.00
股息率:
0.01%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
阿爾凱默斯 - Alixorexton在首次給藥九個月後,於第24周在MWT和ESS上顯示出持續改善
美股速递
·
07/13
高盛:日本企業併購活動尚處初期
格隆汇
·
07/09
高盛:日本企業併購活動正處於「初期階段」
智通财经
·
07/09
阿爾凱默斯與安尼爾終止授權仿製藥供應協議
美股速递
·
07/08
阿爾凱默斯與安尼爾協議終止後,無需承擔罰金或額外義務——SEC文件披露
美股速递
·
07/08
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/PSCH/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PSCH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","market":"US","secType":"STK","nameCN":"Invesco S&P SmallCap Health Care ETF","latestPrice":53.3292,"timestamp":1789416000000,"preClose":52.9516,"halted":0,"volume":10349,"hourTrading":{"tag":"盘后","latestPrice":53.34,"preClose":53.3292,"latestTime":"19:30 EDT","volume":12,"amount":639.8952,"timestamp":1789428601546,"change":0.0108,"changeRate":0.000203,"amplitude":0},"delay":0,"changeRate":0.007131040421819191,"floatShares":3370000,"shares":3370000,"eps":0,"marketStatus":"已收盤","change":0.3776,"latestTime":"09-14 16:00:00 EDT","open":52.99,"high":53.38,"low":52.99,"amount":550982.239907,"amplitude":0.007365,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":52.9516,"sharesOutstanding":3220000,"nav":52.9703,"aum":179039614,"dividendRate":0.000056,"bidAskSpread":0.001851,"preHourTrading":{"tag":"盘前","latestPrice":53,"preClose":52.9516,"latestTime":"09:29 EDT","volume":1480,"amount":78498.02192,"timestamp":1789392599999,"change":0.0484,"changeRate":0.000914,"amplitude":0.00321},"postHourTrading":{"tag":"盘后","latestPrice":53.34,"preClose":53.3292,"latestTime":"19:30 EDT","volume":12,"amount":639.8952,"timestamp":1789428601546,"change":0.0108,"changeRate":0.000203,"amplitude":0},"volumeRatio":0.92728,"impliedVol":0.1092,"impliedVolPercentile":0.7092},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","floatShares":3370000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.92728,"shares":3370000,"dividePrice":0.003,"high":53.38,"amplitude":0.007365,"preClose":52.9516,"low":52.99,"week52Low":39.08,"pbRate":"--","week52High":56.454,"institutionHeld":0,"latestPrice":53.3292,"eps":0,"divideRate":0.000056,"volume":10349,"delay":0,"ttmEps":0,"open":52.99,"prevYearClose":44.0553,"prevWeekClose":52.9516,"prevMonthClose":54.61,"prevQuarterClose":52.3666,"fiveDayClose":54.3614,"twentyDayClose":55.31,"sixtyDayClose":47.9092},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSCH\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"PSCH","amount":0.00033,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-09-22","symbol":"PSCH","amount":0.00259,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PSCH","amount":0.00199,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-24","symbol":"PSCH","amount":0.01419,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSCH","amount":0.01801,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSCH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.01949,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00522,"currency":"USD"},{"executeDate":"2022-03-31","recordDate":null,"paymentDate":"2022-03-31","value":3,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.00448,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.03613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSCH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSCH\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1187620650","title":"阿爾凱默斯 - Alixorexton在首次給藥九個月後,於第24周在MWT和ESS上顯示出持續改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1187620650","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187620650?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 19:03","pubTimestamp":1783940597,"startTime":"0","endTime":"0","summary":"阿尔凯默斯公司宣布,其候选药物Alixorexton在首次给药九个月后,于临床试验的第24周评估中,在维持清醒测试和嗜睡量表两项关键指标上均表现出持续性的改善。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","FBT","PSIL","ALKS","IBRN","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650945691","title":"高盛:日本企業併購活動尚處初期","url":"https://stock-news.laohu8.com/highlight/detail?id=2650945691","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650945691?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 13:08","pubTimestamp":1783573703,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["DEEP","BK4585","JSMD","MSSM","TMFS","PSCH","CAFG","QQQS","SMCO","SPMD","SYLD","BK4588","SCDS","IJS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650945339","title":"高盛:日本企業併購活動正處於「初期階段」","url":"https://stock-news.laohu8.com/highlight/detail?id=2650945339","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650945339?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 12:55","pubTimestamp":1783572940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SMCO","SYLD","SPMD","MSSM","TMFS","DEEP","BK4585","IJS","QQQS","SCDS","CAFG","BK4588","PSCH","JSMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160787890","title":"阿爾凱默斯與安尼爾終止授權仿製藥供應協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1160787890","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160787890?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 20:06","pubTimestamp":1783512380,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会(SEC)的文件,阿尔凯默斯公司与其合作伙伴安尼尔公司已共同决定,自2026年7月6日起,终止双方此前达成的授权仿制药产品供应协议。\n这一变动标志着两家公司在该特定产品合作上的正式分道扬镳。协议的终止将影响相关仿制药未来的市场供应格局。文件披露了这一商业安排的调整,但未进一步阐述终止协议的具体原因或后续财务影响。\n市场参与者将密切关注此举对阿尔凯默斯业务管线及收入构成的潜在影响。同时,安尼尔公司的产品组合也可能因此次合作终止而面临调整。此次战略调整的长期影响,仍有待后续观察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","IBRN","BK4139","PSCH","FBT","MEDX","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155767412","title":"阿爾凱默斯與安尼爾協議終止後,無需承擔罰金或額外義務——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1155767412","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155767412?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 20:06","pubTimestamp":1783512372,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会的文件,阿尔凯默斯与安尼尔在协议终止后,双方均无需支付任何罚金,也无需履行进一步的义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","FBT","MEDX","BK4139","ALKS","IBRN","PSCH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":45,"code":"91000000","status":"200"}]}}